Loading…

Parkin modulates gene expression in control and ceramide-treated PC12 cells

Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether th...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biology reports 2006-03, Vol.33 (1), p.13-32
Main Authors: Unschuld, P G, Dächsel, J, Darios, F, Kohlmann, A, Casademunt, E, Lehmann-Horn, K, Dichgans, M, Ruberg, M, Brice, A, Gasser, T, Lücking, C B
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903
cites cdi_FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903
container_end_page 32
container_issue 1
container_start_page 13
container_title Molecular biology reports
container_volume 33
creator Unschuld, P G
Dächsel, J
Darios, F
Kohlmann, A
Casademunt, E
Lehmann-Horn, K
Dichgans, M
Ruberg, M
Brice, A
Gasser, T
Lücking, C B
description Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether the antiapoptotic effect of parkin involves changes in gene expression, we used Affymetrix oligonucleotide microarrays to analyse gene expression in stably transfected PC12 cells which conditionally overexpress parkin, that were treated or not with C2-ceramide. Overexpression of parkin and ceramide treatment both modulated gene expression. A number of the genes upregulated in the presence of ceramide, and modulated by parkin, were associated with apoptosis or cellular stress reactions. We validated the upregulation of four such genes (CHK, EIF4EBP1, GADD45A and PTPN-5) by real-time PCR after 3, 6, 9 and 12 h of ceramide treatment in cells that overexpressed parkin or not. All were upregulated 2 to 11-fold, 3 and 6 h after application of ceramide. Parkin overexpression reduced the upregulation of EIF4EBP1, GADD45A and PTPN-5, but only at 6 h. These results suggest that, in this assay, the cytoprotective effect of parkin might result not only from its E3-ligase activity, but also from direct or indirect modulation of gene expression in a time-dependent manner.
doi_str_mv 10.1007/s11033-005-3961-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_20481619</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2111128881</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903</originalsourceid><addsrcrecordid>eNpdkE1LxDAQhoMouq7-AC9SPHiLZpqPNkdZ_MIF96DnkLYT6do2a9KC_nuz7ILgaWDmeYeXh5ALYDfAWHEbARjnlDFJuVZA5QGZgSw4FbooD8mMcQZUlBJOyGmMa8aYgEIekxNQiisNYkZeVjZ8tkPW-2bq7Igx-8ABM_zeBIyx9UOWjrUfxuC7zA5NVmOwfdsgHQMmvslWC8jTtuviGTlytot4vp9z8v5w_7Z4osvXx-fF3ZLWXBYjFVZaIZnTUrDSaa6k5qkp5javK6F4ZVVZKls6lad15bBBVzgEyHPIG834nFzv_m6C_5owjqZv47aBHdBP0eRMlKBAJ_DqH7j2UxhSN1MIkdRJLhIEO6gOPsaAzmxC29vwY4CZrWaz02ySZrPVbGTKXO4fT1WPzV9i75X_AoE5dkE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>744033534</pqid></control><display><type>article</type><title>Parkin modulates gene expression in control and ceramide-treated PC12 cells</title><source>Springer Link</source><creator>Unschuld, P G ; Dächsel, J ; Darios, F ; Kohlmann, A ; Casademunt, E ; Lehmann-Horn, K ; Dichgans, M ; Ruberg, M ; Brice, A ; Gasser, T ; Lücking, C B</creator><creatorcontrib>Unschuld, P G ; Dächsel, J ; Darios, F ; Kohlmann, A ; Casademunt, E ; Lehmann-Horn, K ; Dichgans, M ; Ruberg, M ; Brice, A ; Gasser, T ; Lücking, C B</creatorcontrib><description>Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether the antiapoptotic effect of parkin involves changes in gene expression, we used Affymetrix oligonucleotide microarrays to analyse gene expression in stably transfected PC12 cells which conditionally overexpress parkin, that were treated or not with C2-ceramide. Overexpression of parkin and ceramide treatment both modulated gene expression. A number of the genes upregulated in the presence of ceramide, and modulated by parkin, were associated with apoptosis or cellular stress reactions. We validated the upregulation of four such genes (CHK, EIF4EBP1, GADD45A and PTPN-5) by real-time PCR after 3, 6, 9 and 12 h of ceramide treatment in cells that overexpressed parkin or not. All were upregulated 2 to 11-fold, 3 and 6 h after application of ceramide. Parkin overexpression reduced the upregulation of EIF4EBP1, GADD45A and PTPN-5, but only at 6 h. These results suggest that, in this assay, the cytoprotective effect of parkin might result not only from its E3-ligase activity, but also from direct or indirect modulation of gene expression in a time-dependent manner.</description><identifier>ISSN: 0301-4851</identifier><identifier>EISSN: 1573-4978</identifier><identifier>DOI: 10.1007/s11033-005-3961-5</identifier><identifier>PMID: 16636914</identifier><language>eng</language><publisher>Netherlands: Springer Nature B.V</publisher><subject>Age ; Animals ; Apoptosis ; Basal ganglia ; Cell culture ; Cell death ; Central nervous system diseases ; Ceramide ; Ceramides - pharmacology ; DNA microarrays ; Dopamine receptors ; Gadd45A protein ; Gene expression ; Gene Expression Regulation - drug effects ; Humans ; Movement disorders ; Neurodegeneration ; Oligonucleotides ; Parkin protein ; PC12 Cells ; Pheochromocytoma cells ; Rats ; RNA, Messenger - genetics ; Sphingolipid ceramide ; Transcription, Genetic - drug effects ; Transcription, Genetic - genetics ; Ubiquitin-Protein Ligases - genetics ; Ubiquitin-Protein Ligases - metabolism</subject><ispartof>Molecular biology reports, 2006-03, Vol.33 (1), p.13-32</ispartof><rights>Springer 2006.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903</citedby><cites>FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16636914$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Unschuld, P G</creatorcontrib><creatorcontrib>Dächsel, J</creatorcontrib><creatorcontrib>Darios, F</creatorcontrib><creatorcontrib>Kohlmann, A</creatorcontrib><creatorcontrib>Casademunt, E</creatorcontrib><creatorcontrib>Lehmann-Horn, K</creatorcontrib><creatorcontrib>Dichgans, M</creatorcontrib><creatorcontrib>Ruberg, M</creatorcontrib><creatorcontrib>Brice, A</creatorcontrib><creatorcontrib>Gasser, T</creatorcontrib><creatorcontrib>Lücking, C B</creatorcontrib><title>Parkin modulates gene expression in control and ceramide-treated PC12 cells</title><title>Molecular biology reports</title><addtitle>Mol Biol Rep</addtitle><description>Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether the antiapoptotic effect of parkin involves changes in gene expression, we used Affymetrix oligonucleotide microarrays to analyse gene expression in stably transfected PC12 cells which conditionally overexpress parkin, that were treated or not with C2-ceramide. Overexpression of parkin and ceramide treatment both modulated gene expression. A number of the genes upregulated in the presence of ceramide, and modulated by parkin, were associated with apoptosis or cellular stress reactions. We validated the upregulation of four such genes (CHK, EIF4EBP1, GADD45A and PTPN-5) by real-time PCR after 3, 6, 9 and 12 h of ceramide treatment in cells that overexpressed parkin or not. All were upregulated 2 to 11-fold, 3 and 6 h after application of ceramide. Parkin overexpression reduced the upregulation of EIF4EBP1, GADD45A and PTPN-5, but only at 6 h. These results suggest that, in this assay, the cytoprotective effect of parkin might result not only from its E3-ligase activity, but also from direct or indirect modulation of gene expression in a time-dependent manner.</description><subject>Age</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Basal ganglia</subject><subject>Cell culture</subject><subject>Cell death</subject><subject>Central nervous system diseases</subject><subject>Ceramide</subject><subject>Ceramides - pharmacology</subject><subject>DNA microarrays</subject><subject>Dopamine receptors</subject><subject>Gadd45A protein</subject><subject>Gene expression</subject><subject>Gene Expression Regulation - drug effects</subject><subject>Humans</subject><subject>Movement disorders</subject><subject>Neurodegeneration</subject><subject>Oligonucleotides</subject><subject>Parkin protein</subject><subject>PC12 Cells</subject><subject>Pheochromocytoma cells</subject><subject>Rats</subject><subject>RNA, Messenger - genetics</subject><subject>Sphingolipid ceramide</subject><subject>Transcription, Genetic - drug effects</subject><subject>Transcription, Genetic - genetics</subject><subject>Ubiquitin-Protein Ligases - genetics</subject><subject>Ubiquitin-Protein Ligases - metabolism</subject><issn>0301-4851</issn><issn>1573-4978</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><recordid>eNpdkE1LxDAQhoMouq7-AC9SPHiLZpqPNkdZ_MIF96DnkLYT6do2a9KC_nuz7ILgaWDmeYeXh5ALYDfAWHEbARjnlDFJuVZA5QGZgSw4FbooD8mMcQZUlBJOyGmMa8aYgEIekxNQiisNYkZeVjZ8tkPW-2bq7Igx-8ABM_zeBIyx9UOWjrUfxuC7zA5NVmOwfdsgHQMmvslWC8jTtuviGTlytot4vp9z8v5w_7Z4osvXx-fF3ZLWXBYjFVZaIZnTUrDSaa6k5qkp5javK6F4ZVVZKls6lad15bBBVzgEyHPIG834nFzv_m6C_5owjqZv47aBHdBP0eRMlKBAJ_DqH7j2UxhSN1MIkdRJLhIEO6gOPsaAzmxC29vwY4CZrWaz02ySZrPVbGTKXO4fT1WPzV9i75X_AoE5dkE</recordid><startdate>20060301</startdate><enddate>20060301</enddate><creator>Unschuld, P G</creator><creator>Dächsel, J</creator><creator>Darios, F</creator><creator>Kohlmann, A</creator><creator>Casademunt, E</creator><creator>Lehmann-Horn, K</creator><creator>Dichgans, M</creator><creator>Ruberg, M</creator><creator>Brice, A</creator><creator>Gasser, T</creator><creator>Lücking, C B</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20060301</creationdate><title>Parkin modulates gene expression in control and ceramide-treated PC12 cells</title><author>Unschuld, P G ; Dächsel, J ; Darios, F ; Kohlmann, A ; Casademunt, E ; Lehmann-Horn, K ; Dichgans, M ; Ruberg, M ; Brice, A ; Gasser, T ; Lücking, C B</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Age</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Basal ganglia</topic><topic>Cell culture</topic><topic>Cell death</topic><topic>Central nervous system diseases</topic><topic>Ceramide</topic><topic>Ceramides - pharmacology</topic><topic>DNA microarrays</topic><topic>Dopamine receptors</topic><topic>Gadd45A protein</topic><topic>Gene expression</topic><topic>Gene Expression Regulation - drug effects</topic><topic>Humans</topic><topic>Movement disorders</topic><topic>Neurodegeneration</topic><topic>Oligonucleotides</topic><topic>Parkin protein</topic><topic>PC12 Cells</topic><topic>Pheochromocytoma cells</topic><topic>Rats</topic><topic>RNA, Messenger - genetics</topic><topic>Sphingolipid ceramide</topic><topic>Transcription, Genetic - drug effects</topic><topic>Transcription, Genetic - genetics</topic><topic>Ubiquitin-Protein Ligases - genetics</topic><topic>Ubiquitin-Protein Ligases - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Unschuld, P G</creatorcontrib><creatorcontrib>Dächsel, J</creatorcontrib><creatorcontrib>Darios, F</creatorcontrib><creatorcontrib>Kohlmann, A</creatorcontrib><creatorcontrib>Casademunt, E</creatorcontrib><creatorcontrib>Lehmann-Horn, K</creatorcontrib><creatorcontrib>Dichgans, M</creatorcontrib><creatorcontrib>Ruberg, M</creatorcontrib><creatorcontrib>Brice, A</creatorcontrib><creatorcontrib>Gasser, T</creatorcontrib><creatorcontrib>Lücking, C B</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Molecular biology reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Unschuld, P G</au><au>Dächsel, J</au><au>Darios, F</au><au>Kohlmann, A</au><au>Casademunt, E</au><au>Lehmann-Horn, K</au><au>Dichgans, M</au><au>Ruberg, M</au><au>Brice, A</au><au>Gasser, T</au><au>Lücking, C B</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parkin modulates gene expression in control and ceramide-treated PC12 cells</atitle><jtitle>Molecular biology reports</jtitle><addtitle>Mol Biol Rep</addtitle><date>2006-03-01</date><risdate>2006</risdate><volume>33</volume><issue>1</issue><spage>13</spage><epage>32</epage><pages>13-32</pages><issn>0301-4851</issn><eissn>1573-4978</eissn><abstract>Mutations in the parkin gene cause autosomal-recessive early-onset parkinsonism as a result of the degeneration of mesencephalic dopaminergic neurons. In cell culture models, parkin expression has been shown to protect against cell death mediated by the sphingolipid ceramide. To determine whether the antiapoptotic effect of parkin involves changes in gene expression, we used Affymetrix oligonucleotide microarrays to analyse gene expression in stably transfected PC12 cells which conditionally overexpress parkin, that were treated or not with C2-ceramide. Overexpression of parkin and ceramide treatment both modulated gene expression. A number of the genes upregulated in the presence of ceramide, and modulated by parkin, were associated with apoptosis or cellular stress reactions. We validated the upregulation of four such genes (CHK, EIF4EBP1, GADD45A and PTPN-5) by real-time PCR after 3, 6, 9 and 12 h of ceramide treatment in cells that overexpressed parkin or not. All were upregulated 2 to 11-fold, 3 and 6 h after application of ceramide. Parkin overexpression reduced the upregulation of EIF4EBP1, GADD45A and PTPN-5, but only at 6 h. These results suggest that, in this assay, the cytoprotective effect of parkin might result not only from its E3-ligase activity, but also from direct or indirect modulation of gene expression in a time-dependent manner.</abstract><cop>Netherlands</cop><pub>Springer Nature B.V</pub><pmid>16636914</pmid><doi>10.1007/s11033-005-3961-5</doi><tpages>20</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0301-4851
ispartof Molecular biology reports, 2006-03, Vol.33 (1), p.13-32
issn 0301-4851
1573-4978
language eng
recordid cdi_proquest_miscellaneous_20481619
source Springer Link
subjects Age
Animals
Apoptosis
Basal ganglia
Cell culture
Cell death
Central nervous system diseases
Ceramide
Ceramides - pharmacology
DNA microarrays
Dopamine receptors
Gadd45A protein
Gene expression
Gene Expression Regulation - drug effects
Humans
Movement disorders
Neurodegeneration
Oligonucleotides
Parkin protein
PC12 Cells
Pheochromocytoma cells
Rats
RNA, Messenger - genetics
Sphingolipid ceramide
Transcription, Genetic - drug effects
Transcription, Genetic - genetics
Ubiquitin-Protein Ligases - genetics
Ubiquitin-Protein Ligases - metabolism
title Parkin modulates gene expression in control and ceramide-treated PC12 cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A02%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parkin%20modulates%20gene%20expression%20in%20control%20and%20ceramide-treated%20PC12%20cells&rft.jtitle=Molecular%20biology%20reports&rft.au=Unschuld,%20P%20G&rft.date=2006-03-01&rft.volume=33&rft.issue=1&rft.spage=13&rft.epage=32&rft.pages=13-32&rft.issn=0301-4851&rft.eissn=1573-4978&rft_id=info:doi/10.1007/s11033-005-3961-5&rft_dat=%3Cproquest_cross%3E2111128881%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c357t-4a5a450f95408f936593030e2a2cb463ba6886a8f62030bfedef7fe112212d903%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=744033534&rft_id=info:pmid/16636914&rfr_iscdi=true